Cargando…
NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma
CONTEXT: Anaplastic thyroid carcinoma (ATC) represents one of the most aggressive carcinomas with no consistent survival benefit when treated with conventional radiochemotherapy. Approaches targeting “oncogene addiction” of ATC are increasingly explored and first promising results have been reported...
Autores principales: | Tiedje, Vera, Ting, Saskia, Herold, Thomas, Synoracki, Sarah, Latteyer, Soeren, Moeller, Lars C., Zwanziger, Denise, Stuschke, Martin, Fuehrer, Dagmar, Schmid, Kurt Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522092/ https://www.ncbi.nlm.nih.gov/pubmed/28489587 http://dx.doi.org/10.18632/oncotarget.17300 |
Ejemplares similares
-
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma – Lessons From Individual Cases With Long-Term Follow-Up
por: Brandenburg, Tim, et al.
Publicado: (2021) -
Targeting claudin‐overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin
por: Piontek, Anna, et al.
Publicado: (2020) -
The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma – systematic review and discussion of current therapeutic options
por: Rocha, Maria Linda, et al.
Publicado: (2021) -
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line
por: Hegedűs, Luca, et al.
Publicado: (2020) -
Functional Characterization of Olfactory Receptors in the Thyroid Gland
por: Weidinger, Daniel, et al.
Publicado: (2021)